Molecular Imaging: Page 47

GE HealthCare close to completing safety recall

By Amerigo Allegretto

GE HealthCare has nearly completed its previously announced safety recall of the company's 600 and 800 series nuclear medicine systems.

February 23, 2023

SNMMI issues new guideline for PET imaging of neuroendocrine tumors

By Will Morton

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine have released a new practice guideline for somatostatin receptor PET imaging of patients with neuroendocrine tumors.

February 23, 2023

PET scans reveal effects of biologic therapy in psoriasis patients

By Will Morton

PET scans of people with psoriasis treated with anti-inflammatory biologics show the drugs may reduce vascular inflammation associated with cardiovascular disease, according to a study published February 8 in the Journal of Nuclear Cardiology.

February 20, 2023

Blue Earth highlights results from PET tracer trial

By AuntMinnie.com staff writers

Blue Earth Diagnostics is highlighting results from a phase III clinical trial that tested its diagnostic PET imaging radiotracer F-18 rhPSMA-7.3 in newly diagnosed prostate cancer patients.

February 16, 2023

GE HealthCare recalls certain nuclear medicine systems

By Amerigo Allegretto

GE HealthCare is recalling its 600 and 800 Series nuclear medicine systems after identifying an issue with two safety mechanisms that could potentially lead to a "catastrophic fall" of a detector and potentially trap or crush patients.

February 15, 2023

PET/CT shows promise in patients with primary aldosteronism

By Will Morton

Gallium-68 (Ga-68) pentixafor PET/CT imaging may be a promising noninvasive approach for subtyping patients with primary aldosteronism, according to a study published February 16 in JAMA Network Open.

February 15, 2023

Can PET/CT scans replace bone biopsies in lymphoma patients?

By Will Morton

FDG-PET/CT scans may be preferred over invasive biopsies for detecting bone marrow cancer in lymphoma patients, according to research published February 12 in Cureus.

February 13, 2023

PET/CT can influence management of colorectal cancer

By Will Morton

F-18 FDG-PET/CT imaging can detect treatment response in patients with metastatic colorectal cancer, potentially having a significant impact in how they are managed, according to a group in Egypt.

February 12, 2023

Can PET help redefine 'consciousness' in coma patients?

By Will Morton

PET imaging can help reveal mechanisms underlying human consciousness and may play a pivotal role in improving the prognostication and treatment of severely brain-injured patients, according to researchers in Belgium.

February 8, 2023

Brain PET patterns emerge in early Alzheimer's patients

By Will Morton

A computer model derived from amyloid PET scans appears to be able to predict how early Alzheimer's disease will progress in patients based on distinct brain patterns, according to a study published February 2 in Translational Psychiatry.

February 6, 2023

Blood biomarkers may predict cognitive decline in Alzheimer's patients

By Will Morton

Lab tests for plasma tau protein (p-tau217) could be used as a complement to PET imaging for selecting clinical trial participants to test new Alzheimer's disease treatments, according to a study published February 6 in JAMA Neurology.

February 6, 2023

IsoRay completes merger with Viewpoint Molecular Targeting

By AuntMinnie.com staff writers

Medical isotope developer IsoRay has completed its merger with Viewpoint Molecular Targeting. The deal closed on February 3.

February 5, 2023

Previous Page

Page 47 of 612

Next Page